Our Experts in the News
-
Biogen’s $56,000-a-year Alzheimer’s drug reignites US debate over costs
June 8, 2021
Financial Times
-
Hospitals in medical study tested epilepsy drugs without telling patients
June 8, 2021
The Atlanta Journal Constitution
-
States, Medical Regulators and Institutions Must Act to End Physician Sexual Abuse
June 8, 2021
Ms. Magazine
-
A Highly Controversial Alzheimer’s Treatment Won FDA Approval. Scientists Say We Don’t Know If It Actually Works.
June 7, 2021
BuzzFeed News
-
FDA Defends Approval of Controversial Alzheimer's Drug
June 7, 2021
HealthDay
-
FDA's 'intellectually insulting' aducanumab decision opens up a regulatory foothold for leading competitors
June 7, 2021
Fierce Biotech
-
Sunrise stem cell clinic loses appeal of ruling stopping unapproved treatments
June 3, 2021
South Florida Sun-Sentinel
-
F.D.A. Approves Pricey Pill to Treat Vaginal Yeast Infections
June 2, 2021
The New York Times
-
Prominent GI oncologist Axel Grothey was forced out of Mayo Clinic for unethical sexual relationships with women he mentored
May 28, 2021
The Cancer Letter
-
'A hugely consequential decision:' How Biogen's Alzheimer's drug came to face the FDA
May 27, 2021
BioPharma Dive
-
Mind Game
May 23, 2021
Full Measure
-
Did the U.S. FDA Improperly Expedite Remdesivir’s Approval? The Public Citizen Demand Letter to FDA, Plus a TrialSite Perspective
May 22, 2021
TrialSite News
-
FDA reviewers: Why we are against approval of aducanumab for Alzheimer's
May 5, 2021
Medscape
-
Pfizer prepares to file for full FDA approval of its Covid vaccine
May 4, 2021
Financial Buzz
-
FDA is urged to move faster to list medicines withdrawn over safety concerns
April 14, 2021
STAT
-
In-Depth: How full FDA approval would impact vaccine mandates, competition
April 9, 2021
ABC-10 News, San Diego
-
Watchdog calls for probe into 'inappropriate' FDA-Biogen aducanumab collaboration
April 5, 2021
Fierce Biotech
-
FDA panels say new arthritis drug too risky
March 25, 2021
Pain News Network
-
Carcinogen found in hand sanitizers that plugged COVID gap
March 24, 2021
The Seattle Times
-
Pfizer hopes for a happy ending for an osteoarthritis drug with a troubled history
March 24, 2021
STAT